Jardiance

IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Medicare
drug pricing
Inflation Reduction Act
JNJ
Xarelto
Imbruvica
Stelara
Bristol Myers Squibb
Eliquis
Eli Lilly
Jardiance
Merck
Januvia
Amgen
Enbrel
AstraZeneca
Farxiga
Novo Nordisk
Fiasp
Novartis
Entresto
Eli Lilly’s growth drivers, Verzenio and Jardiance, suffer clinical setbacks
Fierce Pharma
Tue, 04/30/24 - 11:20 am
Eli Lilly
Jardiance
Verzenio
clinical trials
Jardiance doesn’t cut it in post-heart attack trial
Pharmaphorum
Mon, 04/8/24 - 11:21 am
Boehringer Ingelheim
Eli Lilly
Jardiance
clinical trials
heart attack
Boehringer Ingelheim pledges €120M to expand Greek plant, add capacity for Jardiance
Fierce Pharma
Fri, 01/12/24 - 09:55 am
Boehringer Ingelheim
drug manufacturing
Greece
Jardiance
FDA greenlights Jardiance for treating chronic kidney disease
Medical Marketing and Media
Fri, 09/22/23 - 11:50 am
Eli Lilly
Boehringer Ingelheim
Medicare
Jardiance
FDA
chronic kidney disease
Boehringer Ingelheim posts more Jardiance growth as potential US kidney disease approval nears
Fierce Pharma
Tue, 08/1/23 - 10:35 pm
Boehringer Ingelheim
Jardiance
diabetes
earnings
Jardiance cleared in EU for CKD, challenging Forxiga
Pharmaphorum
Wed, 07/26/23 - 09:45 am
Boehringer Ingelheim
Eli Lilly
Jardiance
Europe
chronic kidney disease
Forxiga
FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
Benzinga
Tue, 06/20/23 - 09:46 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
Synjardy
type 2 diabetes
pediatric
FDA
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CP Wire
Mon, 04/3/23 - 03:35 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
Mon, 04/3/23 - 03:33 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Boehringer Ingelheim and Eli Lilly's Jardiance gets big lift from heart failure indications
Fierce Pharma
Wed, 03/29/23 - 04:01 pm
Boehringer Ingelheim
Eli Lilly
Jardiance
heart failure
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
television ads
pharma marketing
DTC ads
AbbVie
Rinvoq
Dupixent
Sanofi
Regeneron
Skyrizi
Novo Nordisk
Ozempic
Jardiance
Eli Lilly
Boehringer Ingelheim
Rybelsus
Trulicity
Rexulti
Otsuka
Lundbeck
Tremfya
JNJ
Verzenio
Lilly and Boehringer's Jardiance Racks Up Another Type 2 Diabetes Win
BioSpace
Wed, 12/7/22 - 11:40 pm
Eli Lilly
Boehringer Ingelheim
type 2 diabetes
Jardiance
pediatri
Eli Lilly, Boehringer Ingelheim bolster case for Jardiance to treat chronic kidney disease
Fierce Pharma
Sun, 11/6/22 - 01:44 pm
Eli Lilly
Boehringer Ingelheim
chronic kideny disease
Jardiance
Farxiga
AstraZeneca
Eli Lilly, Boehringer Ingelheim's Jardiance turns up heat on AstraZeneca's Farxiga with broad EU heart failure approval
Fierce Pharma
Mon, 03/7/22 - 10:10 am
Eli Lilly
Boehringer Ingelheim
Jardiance
heart failure
Europe
AstraZeneca
Farxiga
Eli Lilly, Boehringer Ingelheim's Jardiance clinches heart failure edge with FDA nod for wider label
Fierce Pharma
Fri, 02/25/22 - 10:24 am
Eli Lilly
Boehringer Ingelheim
Jardiance
heart failure
FDA
Boehringer-Lilly’s Jardiance obtains FDA priority review to treat heart failure
Pharmaceutical Business Review
Fri, 11/12/21 - 10:37 am
Eli Lilly
Boehringer Ingelheim
Jardiance
priority review
FDA
heart failure
Eli Lilly, Boehringer roll out video game for doctors to highlight cardio-renal-metabolic disease connections
Fierce Pharma
Tue, 10/12/21 - 11:41 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
gamification
Here's What This Label Expansion Could Mean for Eli Lilly Investors
Motley Fool
Sun, 08/29/21 - 11:16 pm
Eli Lilly
Jardiance
heart failure
label expansions
FDA
FDA Approvals Roundup: Korsuva, Jardiance, Xarelto
RAPS.org
Fri, 08/27/21 - 10:36 am
Cara Therapeutics
Korsuva
Boehringer Ingelheim
Jardiance
Bristol Myers Squibb
Opdivo

Pages